APA (7th ed.) Citation

Riecke, K., Chattopadhyay, N., Ligges, S., Zimmermann, T., Kohnke, A., Halabi, A., & Schultze-Mosgau, M. (2018). Safety and pharmacokinetics (PK) of the progesterone receptor modulator vilaprisan in subjects with impaired liver function. Fertility and sterility, 110(4), e135. https://doi.org/10.1016/j.fertnstert.2018.07.401

Chicago Style (17th ed.) Citation

Riecke, K., N. Chattopadhyay, S. Ligges, T. Zimmermann, A. Kohnke, A. Halabi, and M. Schultze-Mosgau. "Safety and Pharmacokinetics (PK) of the Progesterone Receptor Modulator Vilaprisan in Subjects with Impaired Liver Function." Fertility and Sterility 110, no. 4 (2018): e135. https://doi.org/10.1016/j.fertnstert.2018.07.401.

MLA (9th ed.) Citation

Riecke, K., et al. "Safety and Pharmacokinetics (PK) of the Progesterone Receptor Modulator Vilaprisan in Subjects with Impaired Liver Function." Fertility and Sterility, vol. 110, no. 4, 2018, p. e135, https://doi.org/10.1016/j.fertnstert.2018.07.401.